Oza AM - Search Results

1

A phase I study of the Wee1 kinase inhibitor adavosertib (AZD1775) in combination with chemoradiation in cervical, upper vaginal, and uterine cancers.

Gonzalez-Ochoa E, Milosevic M, Corr B, Abbruzzese JL, Girda E, Miller RW, Croke J, Mackay H, Lee YC, Bowering V, Ramsahai J, Wang L, D'Souza A, Kunos CA, Oza AM, Lheureux S. Gonzalez-Ochoa E, et al. Among authors: oza am. Int J Gynecol Cancer. 2023 Aug 7;33(8):1208-1214. doi: 10.1136/ijgc-2023-004491. Int J Gynecol Cancer. 2023. PMID: 37380217 Free PMC article. Clinical Trial.

2

Consolidative abdominopelvic radiotherapy after surgery and carboplatin/paclitaxel chemotherapy for epithelial ovarian cancer.

Dinniwell R, Lock M, Pintilie M, Fyles A, Laframboise S, Depetrillo D, Levin W, Manchul L, Murphy J, Oza A, Rosen B, Sturgeon J, Milosevic M. Dinniwell R, et al. Int J Radiat Oncol Biol Phys. 2005 May 1;62(1):104-10. doi: 10.1016/j.ijrobp.2004.09.010. Int J Radiat Oncol Biol Phys. 2005. PMID: 15850909

3

A phase II trial with pharmacodynamic endpoints of the proteasome inhibitor bortezomib in patients with metastatic colorectal cancer.

Mackay H, Hedley D, Major P, Townsley C, Mackenzie M, Vincent M, Degendorfer P, Tsao MS, Nicklee T, Birle D, Wright J, Siu L, Moore M, Oza A. Mackay H, et al. Clin Cancer Res. 2005 Aug 1;11(15):5526-33. doi: 10.1158/1078-0432.CCR-05-0081. Clin Cancer Res. 2005. PMID: 16061869 Clinical Trial.

4

Phase II multicenter open-label study of carboplatin and pegylated liposomal doxorubicin in uterine and cervical malignancies.

Lê LH, Swenerton KD, Elit L, Provencher DM, Stuart GC, LE T, Lee U, Rodgers A, Pond GR, Hu H, Oza AM. Lê LH, et al. Among authors: oza am. Int J Gynecol Cancer. 2005 Sep-Oct;15(5):799-806. doi: 10.1111/j.1525-1438.2005.00139.x. Int J Gynecol Cancer. 2005. PMID: 16174227 Free article. Clinical Trial.

5

Uterine papillary serous carcinoma: evaluation of multimodality treatment with abdominopelvic radiotherapy and chemotherapy.

Steed H, Manchul L, Rosen B, Fyles A, Lockwood G, Laframboise S, Murphy J, Milosevic M, Chapman W, Oza AM. Steed H, et al. Among authors: oza am. Int J Gynecol Cancer. 2006 Jan-Feb;16 Suppl 1:278-85. doi: 10.1111/j.1525-1438.2006.00420.x. Int J Gynecol Cancer. 2006. PMID: 16515604

6

A prospective phase I-II trial of the cyclooxygenase-2 inhibitor celecoxib in patients with carcinoma of the cervix with biomarker assessment of the tumor microenvironment.

Herrera FG, Chan P, Doll C, Milosevic M, Oza A, Syed A, Pintilie M, Levin W, Manchul L, Fyles A. Herrera FG, et al. Int J Radiat Oncol Biol Phys. 2007 Jan 1;67(1):97-103. doi: 10.1016/j.ijrobp.2006.08.024. Epub 2006 Oct 23. Int J Radiat Oncol Biol Phys. 2007. PMID: 17056201 Clinical Trial.

7

Chemotherapy for recurrent, metastatic, or persistent cervical cancer: a systematic review.

Hirte HW, Strychowsky JE, Oliver T, Fung-Kee-Fung M, Elit L, Oza AM. Hirte HW, et al. Among authors: oza am. Int J Gynecol Cancer. 2007 Nov-Dec;17(6):1194-204. doi: 10.1111/j.1525-1438.2007.00900.x. Epub 2007 Jun 1. Int J Gynecol Cancer. 2007. PMID: 17540006 Review.

8

Evaluation of an intraperitoneal chemotherapy program implemented at the Princess Margaret Hospital for patients with epithelial ovarian carcinoma.

Chin SN, Pinto V, Rosen B, Oza A, Dodge J, Murphy J, Mackay H. Chin SN, et al. Gynecol Oncol. 2009 Mar;112(3):450-4. doi: 10.1016/j.ygyno.2008.11.021. Epub 2009 Jan 10. Gynecol Oncol. 2009. PMID: 19135709 Clinical Trial.

9

A phase II study of sunitinib in patients with locally advanced or metastatic cervical carcinoma: NCIC CTG Trial IND.184.

Mackay HJ, Tinker A, Winquist E, Thomas G, Swenerton K, Oza A, Sederias J, Ivy P, Eisenhauer EA. Mackay HJ, et al. Gynecol Oncol. 2010 Feb;116(2):163-7. doi: 10.1016/j.ygyno.2009.08.012. Epub 2009 Sep 8. Gynecol Oncol. 2010. PMID: 19740535 Clinical Trial.

10

A dose-escalation phase I trial of nimotuzumab, an antibody against the epidermal growth factor receptor, in patients with advanced solid malignancies.

You B, Brade A, Magalhaes JM, Siu LL, Oza A, Lovell S, Wang L, Hedley DW, Nicacio LV, Chen EX. You B, et al. Invest New Drugs. 2011 Oct;29(5):996-1003. doi: 10.1007/s10637-010-9444-0. Epub 2010 May 8. Invest New Drugs. 2011. PMID: 20454832 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

303 results

Search Page